Tag: Novartis Pharmaceuticals Corporation

The Galien Foundation Announces 2025 Prix Galien USA Nominees for “Best Biotechnology Product,” “Best Pharmaceutical Product” and “Best Product for Rare/Orphan Diseases”

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the...

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsNovartis Pharmaceuticals Corporation

SpringGreen Reaches $100 Million in Revenue, Honors Record-Breaking Franchise owner at National Training Conference

Boyd Group Services Inc. Reports Second Quarter 2025 Results

China Automotive Systems Reports Income From Operations Increased by 20.2% in the Second Quarter of 2025

Tag: Novartis Pharmaceuticals Corporation

The Galien Foundation Announces 2025 Prix Galien USA Nominees for “Best Biotechnology Product,” “Best Pharmaceutical Product” and “Best Product for Rare/Orphan Diseases”

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us